Ribonuclease/angiogenin Inhibitor 1 (RNH1) (Middle Region) Peptide
RNH1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all RNH1 products
- RNH1 (Ribonuclease/angiogenin Inhibitor 1 (RNH1))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-RNH1 antibody (Catalog #: ARP57821_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- RNH1 (Ribonuclease/angiogenin Inhibitor 1 (RNH1))
- Background
-
RNH1 is the inhibitor of pancreatic RNase and angiogenin. RNH1 may also function in the modulation of cellular activities.
Alias Symbols: MGC18200, MGC4569, MGC54054, RAI, RNH
Protein Interaction Partner: ANG,RNASE1,ANG,C20orf94,G3BP2,LOC220594,TNFAIP3
Protein Size: 461 - Molecular Weight
- 50 kDa
- Gene ID
- 6050
- NCBI Accession
- NM_203387, NP_976321
- UniProt
- P13489
-
You are here:
